How Bacterial Vesicles Influence Female Fertility and Early Pregnancy

How Bacterial Nanovesicles Interact with Human Tissue

Bacterial extracellular vesicles act as microscopic transport packages that deliver information from bacteria to human cells, according to Hannah Wein, a doctoral student and co-first author of the study at the Clinic and Polyclinic for Gynecology and Obstetrics at University Medicine Greifswald. Wein noted that while bacteria are frequently associated with infections, many reside naturally in the human body—including the gut, skin, and female genital tract—where they protect against pathogens and influence the immune system. Because the presence of bacterial genetic material in the uterus does not confirm whether live bacteria are permanently resident or simply remnants of dead cells and vesicles, these nanovesicles offer a potential explanation for how the microbiome affects the uterus during early pregnancy.

Implications for Early Pregnancy and Fetal-Maternal Communication

The overview study evaluated five investigations using human biological samples and 14 cell culture studies focusing on female reproduction and pregnancy. According to the findings, vesicles originating from beneficial lactic acid bacteria can strengthen natural tissue defense and hinder the colonization of pathogens. Conversely, vesicles from harmful bacteria may trigger inflammatory responses and weaken protective tissue barriers. PD Dr. Damián Muzzio, head of the research laboratory at the Greifswald University Women’s Hospital and a lead author of the study, stated that bacterial vesicles offer a new perspective on microbiome-host communication at the fetomaternal interface, building on research themes established by clinic director Professor Zygmunt and his team over the past two decades.

Future Research Directions and Clinical Potential

Before any diagnostic or therapeutic applications emerge, researchers must conduct deeper investigations into vesicle mechanisms and develop reliable detection methods. According to Prof. Dr. Karlhans Endlich, Scientific Board Member at University Medicine Greifswald, the findings underscore the importance of exploring new biological concepts to better understand fertility disorders and pregnancy complications. Long-term possibilities include utilizing specific vesicle compositions as biomarkers for fertility issues or testing targeted treatments using vesicles from beneficial bacteria, pending safety and efficacy evaluations for both mother and child. The collaborative study included researchers from University Medicine Greifswald, the Karolinska Institute and Karolinska University Hospital in Sweden, as well as the University of Tartu and the research firm Celvia in Estonia.